The estimated Net Worth of Cheryl L White is at least $755 Тысяча dollars as of 22 September 2008. Cheryl White owns over 37,400 units of Baxter International stock worth over $754,691 and over the last 19 years Cheryl sold BAX stock worth over $0.
Cheryl has made over 1 trades of the Baxter International stock since 2008, according to the Form 4 filled with the SEC. Most recently Cheryl exercised 37,400 units of BAX stock worth $1,546,116 on 22 September 2008.
The largest trade Cheryl's ever made was exercising 37,400 units of Baxter International stock on 22 September 2008 worth over $1,546,116. On average, Cheryl trades about 2,877 units every 0 days since 2006. As of 22 September 2008 Cheryl still owns at least 19,218 units of Baxter International stock.
You can see the complete history of Cheryl White stock trades at the bottom of the page.
Cheryl's mailing address filed with the SEC is ONE BAXTER PARKWAY, , DEERFIELD, IL, 60015.
Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney и Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Baxter International executives and other stock owners filed with the SEC include: